BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17693187)

  • 21. The zebrafish as a model for studying neuroblastoma.
    Corallo D; Candiani S; Ori M; Aveic S; Tonini GP
    Cancer Cell Int; 2016; 16():82. PubMed ID: 27822138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome instability model of metastatic neuroblastoma tumorigenesis by a dictionary learning algorithm.
    Masecchia S; Coco S; Barla A; Verri A; Tonini GP
    BMC Med Genomics; 2015 Sep; 8():57. PubMed ID: 26358114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma.
    Ackermann S; Kocak H; Hero B; Ehemann V; Kahlert Y; Oberthuer A; Roels F; Theißen J; Odenthal M; Berthold F; Fischer M
    BMC Cancer; 2014 Nov; 14():840. PubMed ID: 25406647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neuroblastoma and ganglion components of nodular ganglioneuroblastoma are genetically similar: evidence against separate clonal origins.
    Angelini P; Baruchel S; Marrano P; Irwin MS; Thorner PS
    Mod Pathol; 2015 Feb; 28(2):166-76. PubMed ID: 25081755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High genomic instability predicts survival in metastatic high-risk neuroblastoma.
    Stigliani S; Coco S; Moretti S; Oberthuer A; Fischer M; Theissen J; Gallo F; Garavent A; Berthold F; Bonassi S; Tonini GP; Scaruffi P
    Neoplasia; 2012 Sep; 14(9):823-32. PubMed ID: 23019414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors.
    Kryh H; Carén H; Erichsen J; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
    BMC Genomics; 2011 Sep; 12():443. PubMed ID: 21899760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication.
    Wolf M; Korja M; Karhu R; Edgren H; Kilpinen S; Ojala K; Mousses S; Kallioniemi A; Haapasalo H
    BMC Cancer; 2010 May; 10():181. PubMed ID: 20444257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.
    Carén H; Kryh H; Nethander M; Sjöberg RM; Träger C; Nilsson S; Abrahamsson J; Kogner P; Martinsson T
    Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4323-8. PubMed ID: 20145112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma.
    Scaruffi P; Stigliani S; Moretti S; Coco S; De Vecchi C; Valdora F; Garaventa A; Bonassi S; Tonini GP
    BMC Cancer; 2009 Dec; 9():441. PubMed ID: 20003513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
    Carén H; Erichsen J; Olsson L; Enerbäck C; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
    BMC Genomics; 2008 Jul; 9():353. PubMed ID: 18664255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma.
    Villamón E; Piqueras M; Mackintosh C; Alonso J; de Alava E; Navarro S; Noguera R
    Virchows Arch; 2008 Jul; 453(1):47-55. PubMed ID: 18574593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.
    Selzer RR; Richmond TA; Pofahl NJ; Green RD; Eis PS; Nair P; Brothman AR; Stallings RL
    Genes Chromosomes Cancer; 2005 Nov; 44(3):305-19. PubMed ID: 16075461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.
    McArdle L; McDermott M; Purcell R; Grehan D; O'Meara A; Breatnach F; Catchpoole D; Culhane AC; Jeffery I; Gallagher WM; Stallings RL
    Carcinogenesis; 2004 Sep; 25(9):1599-609. PubMed ID: 15090470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-resolution cDNA microarray-based comparative genomic hybridization analysis in neuroblastoma.
    Chen QR; Bilke S; Khan J
    Cancer Lett; 2005 Oct; 228(1-2):71-81. PubMed ID: 15951107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.
    Scaruffi P; Coco S; Cifuentes F; Albino D; Nair M; Defferrari R; Mazzocco K; Tonini GP
    Cancer Genet Cytogenet; 2007 Aug; 177(1):20-9. PubMed ID: 17693187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.
    Spitz R; Oberthuer A; Zapatka M; Brors B; Hero B; Ernestus K; Oestreich J; Fischer M; Simon T; Berthold F
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1130-42. PubMed ID: 16958102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Origin and functional significance of large-scale chromosomal imbalances in neuroblastoma.
    Stallings RL
    Cytogenet Genome Res; 2007; 118(2-4):110-5. PubMed ID: 18000361
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.